ES75
TEAS SECTION 71 & 15 RECEIVED
06/07/2026
Voltar para busca
Dado oficial do USPTO
EUROFINS DISCOVERX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
45
Atualização mais recente
09/07/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 9, 42
Data de depósito
07/09/2018
Data de registro
21/07/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
21/07/2020
Última transação
09/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
Dungarvan Co Waterford, IE
Examinador
MCMORROW, JANICE LEE
Unidade examinadora
M60
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of "EUROFINS DISCOVERX" with a vertical line between the terms and a dotted design to the left of the word "EUROFINS. DISCOVERX" is placed slightly lower than the word "EUROFINS".
Titulares e representantes
Titulares
EUROFINS SCIENTIFIC (IRELAND) LIMITED Société de droit irlandais
Representantes
JOSEPH SOFER, ESQ. IPSILON USA
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical preparations for discovery of new pharmaceutical productsnot for medical use; diagnostic preparations used in science; diagnostic reagents for scientific use; test kits for analysis and diagnosis for scientific use and for use in the field of researchreagents and buffers; chemical compounds for scientific use and for use in the field of researchnot for medical useoligonucleotidespolynucleotidessynthetic genes; oligonucleotide sequences for DNA microchips; gene librariescollections and variations of DNA fragments for scientific use; genetic engineering materialsgenesfragments and combinations thereof for scientific use
Classe 5
Diagnostic preparations for medical and veterinary use; chemical analysis reagents for medical and veterinary use; biological reagents for medical and veterinary usereagents used for immunological methodsfor the identification and quantification of protein type structures and fragments thereof; diagnostic reagents for medical and veterinary use; chemical reagents for medical and veterinary use; oligonucleotides and polynucleotides for medical and veterinary use; synthetic genes for medical and veterinary use; oligonucleotide sequences for DNA microchips for medical and veterinary use; gene librariescollections and variations of DNA fragments for medical and veterinary usegenetic engineering materialsgenesfragments and combinations thereof for medical and veterinary use
Classe 9
DNA chips; peptide chips; DNA microchips; peptide microchips; biochips
Classe 42
Research and development in the fields of animal and plant biologyphysical chemistry and microbiology; carrying out physicalchemicalphysical-chemicalbiochemicalbiological or microbiological analyses in the fields of plant and animal products; carrying out physicalchemicalphysical-chemicalbiochemicalbiological or microbiological analyses in the field of the foodchemicalpharmaceuticalcosmetic and environmental industry; carrying out genetic analyses in the fields of plant and animal products; carrying out genetic analyses in the foodchemicalpharmaceuticalcosmetic and environmental industries; carrying out nuclear magnetic resonance analyses in the foodchemicalpharmaceuticalcosmetic and environmental industries; scientific and industrial research; development of methodsestablishment and maintenance of chemicalbiological and biomolecular testing methods; providing scientificmedical or industrial expert reports by scientists and engineers in the field of chemistrybiochemistryimmunologypharmacologybiology and physiology for scientists and engineers; technical project studies; professional consultations in the field of scientific research and treatments in the field of chemistrybiochemistryimmunologypharmacologybiology and physiology
Publicações
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
21/07/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/04/2021
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
10/11/2020
XXCR
GENERIC MADRID TRANSACTION CREATED
10/11/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
21/10/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
21/07/2020
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/06/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/05/2020
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
27/05/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/05/2020
PUBO
PUBLISHED FOR OPPOSITION
05/05/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/04/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/03/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
26/03/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
26/03/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
26/03/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
26/03/2020
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
25/03/2020
GNSF
SUBSEQUENT FINAL EMAILED
25/03/2020
CFRC
SUBSEQUENT FINAL REFUSAL WRITTEN
25/03/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/03/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/03/2020
ALIE
ASSIGNED TO LIE
02/03/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
26/02/2020
CNFR
FINAL REFUSAL MAILED
05/09/2019
CNFR
FINAL REFUSAL WRITTEN
05/09/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/08/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/08/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/08/2019
RFNT
REFUSAL PROCESSED BY IB
08/03/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
20/02/2019
RFRR
REFUSAL PROCESSED BY MPU
20/02/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/02/2019
CNRT
NON-FINAL ACTION WRITTEN
07/02/2019
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
07/02/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
29/01/2019
CNRT
NON-FINAL ACTION WRITTEN
28/01/2019
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
24/01/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/01/2019
CNRT
NON-FINAL ACTION WRITTEN
08/01/2019
MAFR
APPLICATION FILING RECEIPT MAILED
08/01/2019
DOCK
ASSIGNED TO EXAMINER
03/01/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/01/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
27/12/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EUROFINS DISCOVERX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.